Montelukast (Singulair) for perennial allergic rhinitis.
D000085:Acetates / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D018592:Cross-Over Studies; D003521:Cyclopropanes; D051544:Cytochrome P-450 CYP3A; D065607:Cytochrome P-450 Enzyme Inhibitors; D004347:Drug Interactions; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D011804:Quinolines / Q000009:adverse effects / Q000627:therapeutic use*; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy*; D013440:Sulfides
D000085:Acetates; D003521:Cyclopropanes; D065607:Cytochrome P-450 Enzyme Inhibitors; D004791:Enzyme Inhibitors; D011804:Quinolines; D013440:Sulfides; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A; C093875:montelukast